AEterna Zentaris, Inc. (AEZS)edit this page

From ValueWiki

Disambiguation: Aeterna Zentaris is a Canadian company that is also listed in Toronto Stock exchange under the ticker AEZ:CA. For main article please visit AEZ:CA.

[edit] Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

[edit] News Feed

03/01/10 7:03 am	Æterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for Perifosine for the Treatment of Multiple Myeloma from the Committee for Orphan Medicinal Products of the European Medicines Agency (PR Newswire)
02/25/10 4:02 pm	5 Stocks That Laugh at Wall Street (at Motley Fool)
02/23/10 8:02 am	Æterna Zentaris CEO to Take Part in Panel Discussion on Cancer Therapy at Upcoming RBC Capital Markets Healthcare Conference in New York on March 3 (PR Newswire)
02/03/10 8:02 am	Æterna Zentaris Partner Keryx Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-0401) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer (PR Newswire)
01/29/10 8:01 am	Æterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia (PR Newswire)
01/29/10 8:01 am	Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia (PR Newswire)
01/29/10 7:01 am	Biotech Stock Mailbag: Keryx Biopharmaceuticals (at TheStreet.com)
01/27/10 4:01 pm	Keryx Biopharmaceuticals, Inc. to Conduct Conference Call to Discuss KRX-0401 (Perifosine) Clinical Development Program in Colorectal Cancer (PR Newswire)
01/26/10 9:01 am	Liberty Analytics Co. Initiates Independent Research Coverage on AEterna Zentaris Inc. (GlobeNewswire)
01/25/10 8:01 am	Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colo (PR Newswire)

More News...

[edit] Risks

This section needs content! Click the blue edit link (to the right) to contribute.

[edit] Research Links

AEterna Zentaris, Inc. Snapshot

• Profile at Yahoo Finance
• Profile at MoneyCentral.com
• Company Events
• Earnings Estimates
• Competitors at Yahoo Finance

AEterna Zentaris, Inc. Leadership

• Officers and Directors at Reuters
• Salaries and Compensation at Reuters
• Insider Trades at Money Central
• Insider Trades at TheStreet.com
• Institutional Ownership at Money Central

AEterna Zentaris, Inc. Fundamentals

• Key Statistics Yahoo Finance
• Key Ratios at Reuters
• Dividends and Returns at Morningstar
• SEC Filings at Edgar Online
• Financial Statements Quickview at Morningstar
• Historical Prices at Yahoo Finance
• Analyst Estimates
• All Press Articles

AEterna Zentaris, Inc. Technical Analysis

• TA at DeepMarket
• Advanced Charts at BigCharts.com
• TA at Yahoo Finance

AEterna Zentaris, Inc. Message Boards

• Yahoo Finance
• Raging Bull
• ValueWiki Message Board
• ValueWiki Chat

[edit] Notes

1. ↑ This is a sample reference.